Meanwhile, it has also been reported that blocking TGF‐β signaling, such as TGF‐β receptor II (TGF‐βRII), in CD4+ T cells mediates tumor regression by promoting the remodeling of the blood vasculature, which means a mature and organized tumor vasculature.417, 418. The gene discussed is TGFB1; the disease is neoplasm.